Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone Levels and Sevoflurane MACBAR under Remifentanil TCI
ChiCTR2100047761Phase 4Not yet recruiting
- Sponsor
- Zhongshan Boai Hospital
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil (2 arms), sponsored by Zhongshan Boai Hospital. Primary endpoints: Minimum alveolar concentration during autonomic blockade of sevoflurane (MACBAR) and Serum progesterone concentration. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2100047761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047761.